Status:

COMPLETED

Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis

Lead Sponsor:

Erasmus Medical Center

Collaborating Sponsors:

Gilead Sciences

Nexstar Pharmaceuticals

Conditions:

Aspergillosis

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

A Phase II/III randomized double-blind study comparing the safety and the efficacy of a weekly administration of 25 mg nebulized AmBisome with nebulized placebo solution to prevent invasive pulmonary ...

Detailed Description

The morbidity, mortality and costs of invasive pulmonary aspergillosis (IPA) in neutropenic patients are high. An effective intervention to prevent IPA would therefore be welcome. The incidence of IPA...

Eligibility Criteria

Inclusion

  • Male or female hospitalized patients aged \> 18 yr
  • The patient has a hematologic malignancy or will receive a bone-marrow transplant
  • The patient starts with a course of chemotherapy within 4 days or is already neutropenic at admission
  • The expected duration of severe neutropenia (PMN\<0.5x10\*9/L) following study entry is \> 10 days
  • The patient is receiving oral antibiotic prophylaxis and fluconazole
  • Written informed consent has been obtained

Exclusion

  • The patient shows evidence of a pulmonary fungal infection or a fungal sinusitis at trial entry
  • The concomitant use of systemic anti-aspergillus treatment such as itraconazole or any intravenous formulation of amphotericin B at study entry
  • Known hypersensitivity to amphotericin B
  • Any evidence of pneumonia or pneumonitis at trial entry
  • Any impossibility to use a nebulizer properly
  • Expected survival \< 3 months at entry
  • Pregnancy

Key Trial Info

Start Date :

January 1 2000

Trial Type :

INTERVENTIONAL

End Date :

May 1 2006

Estimated Enrollment :

320 Patients enrolled

Trial Details

Trial ID

NCT00263315

Start Date

January 1 2000

End Date

May 1 2006

Last Update

August 18 2006

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Erasmus MC centrumlocatie

Rotterdam, Netherlands

2

Erasmus MC locatie Daniel den Hoed

Rotterdam, Netherlands